TLMD - TLMD STOCK NEWS

SOC Telemed (NASDAQ: TLMD) reported strong growth in Q2 2021, with total consults reaching 130,214, a 98% year-over-year increase. Key highlights include a successful telePsychiatry expansion with UnityPoint Health, contributing significant cost savings. Revenue totaled $25 million, up 84%, but a net loss of $14.5 million was noted. The company revised its 2021 revenue guidance to $90-$92 million, down from the previous $97-$103 million, citing impacts from the Delta variant and strategic shifts. As of June 30, 2021, SOC had $50 million in cash.

SOC Telemed (NASDAQ: TLMD) has expanded its partnership with UnityPoint Health, adding telePsychiatry services in four new hospitals across two markets. Building on a successful three-year collaboration, this expansion includes the introduction of the Telemed IQ telemedicine platform in Des Moines and Cedar Rapids, Iowa. The partnership has already shown promising results, including an 11.87-hour reduction in average length of stay for mental health patients and $1.7 million in annualized boarding cost savings at Allen Hospital. The services are expected to go live in the second half of 2021.

SOC Telemed, Inc. (NASDAQ: TLMD) announced a corporate and financial update for Q2 2021 set for August 12, 2021, after market close. The management team will host a conference call and audio webcast at 5:00 p.m. ET. Investors can join the call by dialing domestic (877) 870-4263 or international (412) 317-0790, with the passcode referencing the SOC Telemed call. SOC Telemed is a leader in acute telemedicine technology, providing solutions across multiple specialties.

SOC Telemed (TLMD) has announced a public offering of 8,000,000 shares of Class A Common Stock at $6.00 per share, aiming for gross proceeds of approximately $48 million. The underwriters have a 30-day option to purchase an additional 1,200,000 shares. The closing of the offering is set for June 1, 2021. Proceeds will be primarily used to repay outstanding debt related to the acquisition of Access Physicians, with remaining funds allocated for working capital and general corporate needs.

SOC Telemed (Nasdaq: TLMD) has launched a public offering of 8,000,000 shares of its Class A Common Stock, with an additional 1,200,000 share option for underwriters. Proceeds will be used to repay debt from the acquisition of Access Physicians and for general corporate purposes. The offering's completion is subject to market conditions. Credit Suisse, William Blair, and Guggenheim Securities are the joint book-running managers. A registration statement has been filed with the SEC but is not yet effective. The preliminary prospectus is available on the SEC's website.

SOC Telemed (Nasdaq: TLMD) is expanding its partnership with SCP Health to enhance telemedicine services nationwide. This collaboration aims to optimize acute care workflows, benefiting over 800 partner facilities. The Telemed IQ platform will facilitate a hybrid approach of onsite and virtual care, boosting SCP's clinical workforce efficiency. SCP CEO Rich D'Amaro expressed confidence in the partnership's potential to advance telehealth during a transformative healthcare period. The partnership builds on previous successes during the pandemic, showcasing both companies' commitment to overcoming geographic barriers in patient care.

SOC Telemed (TLMD), the largest national provider of acute care telemedicine, reported Q1 2021 results emphasizing a strong start to the year, with significant growth in patient consult volume, particularly in psychiatry. The company achieved $14.8 million in revenue, maintaining the same level as last year, with a pro forma revenue of $22.8 million post-acquisition of Access Physicians. While net loss increased to $(12.6) million, adjusted gross margins improved to 42%. SOC reaffirms its guidance for 2021, expecting revenue between $97-$103 million.

SOC Telemed (Nasdaq: TLMD) will release its first quarter 2021 financial results on May 13, 2021, after market close. A conference call will follow at 4:00 p.m. E.T. the same day, accessible via phone or live audio webcast. SOC Telemed is the leading provider of acute telemedicine services, enhancing patient outcomes through its technology platform, Telemed IQ. The company aims to support healthcare organizations in developing sustainable telemedicine programs across multiple specialties, significantly impacting clinical care.

SOC Telemed, Inc. (Nasdaq: TLMD), a leading provider of acute care telemedicine, has received The Joint Commission's Gold Seal of Approval for Ambulatory Health Care Accreditation, confirming its compliance with high performance standards. The accreditation process involved a rigorous review in March 2021, evaluating areas like patient care and treatment. SOC Telemed, accredited since 2006, aims to uphold the highest standards of quality and safety in telemedicine. The partnership with Access Physicians, also accredited, emphasizes their commitment to quality care.